Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management
Biology · 28.01.2026 · 15 (3) · 241
DOI: 10.3390/biology15030241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 28.01.2026. Verfasst von Shakta Mani Satyam und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiometabolic diseases, including hypertension, type 2 diabetes, dyslipidemia, and obesity, along with their cardiovascular complications, remain leading causes of morbidity and mortality worldwide, imposing significant public health, economic, and societal burdens. Conventional pharmacological therapies often show limited efficacy and increased adverse effects because they do not account for the body’s intrinsic circadian rhythms, which regulate organ function, drug absorption, and metabolism. Chronopharmacology, which aligns treatment timing with these biological rhythms, offers a strategy to enhance therapeutic outcomes. This review presents a comprehensive analysis of chronopharmacology principles applied to cardiometabolic disease management, integrating molecular, physiological, and clinical perspectives. It examines how core clock genes and tissue-specific circadian patterns influence drug action and absorption and summarizes evidence-based time-optimized interventions for hypertension, diabetes, dyslipidemia, obesity, and multimorbid patients. Furthermore, the review highlights emerging innovations, including artificial intelligence-guided dosing, circadian-biomarker-informed therapy selection, and wearable digital devices for real-time monitoring of biological rhythms. By synthesizing mechanistic and clinical insights, circadian-aligned treatment strategies are shown to improve drug efficacy, reduce adverse effects, and support the development of precision, rhythm-based therapeutics, offering a practical framework for personalized cardiometabolic disease care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
- Department of Perfusion Technology, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
- RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
- Department of Internal Medicine, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
- Department of Pathology, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.
- Royal Cornwall Hospital Trust, National Health Service (NHS), Truro TR1 3LJ, UK.
ORCID-Profile: Shakta Mani Satyam, Sainath Prabhakar, Bhoomendra Bhongade, Adil Farooq Wali, Ismail Ibrahim Ali Matalka, Manfredi Rizzo, Ioannis Ilias, Anna Paczkowska, Karolina Hoffmann
Zitieren
APA
Satyam, S. M., Prabhakar, S., El-Tanani, M., Bhongade, B., Wali, A. F., Rangraze, I. R., Matalka, I. I. A., El-Tanani, Y., Rizzo, M., Ispas, S., Ilias, I., Paczkowska, A., Maggio, V., & Hoffmann, K. (2026). Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management. Biology, 15(3), 241. https://doi.org/10.3390/biology15030241
Vancouver
Satyam SM, Prabhakar S, El-Tanani M, Bhongade B, Wali AF, Rangraze IR, et al. Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management. Biology. 2026;15(3):241. doi:10.3390/biology15030241
BibTeX
@article{Satyam2026,
author = {Satyam, Shakta Mani and Prabhakar, Sainath and El-Tanani, Mohamed and Bhongade, Bhoomendra and Wali, Adil Farooq and Rangraze, Imran Rashid and Matalka, Ismail Ibrahim Ali and El-Tanani, Yahia and Rizzo, Manfredi and Ispas, Sorina and Ilias, Ioannis and Paczkowska, Anna and Maggio, Viviana and Hoffmann, Karolina},
title = {Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management},
journal = {Biology},
year = {2026},
volume = {15},
number = {3},
pages = {241},
doi = {10.3390/biology15030241}
}
EUVIMED